Arrowhead Pharmaceuticals
ARWR
#2281
Rank
ยฃ6.13 B
Marketcap
ยฃ43.44
Share price
1.22%
Change (1 day)
43.39%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -ยฃ1.43

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ2.49. In 2022 the company made an earnings per share (EPS) of -ยฃ1.09 an increase over its 2021 EPS that were of -ยฃ1.31.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.4331.4%
2022-ยฃ1.09-17.05%
2021-ยฃ1.3174.26%
2020-ยฃ0.75-283.64%
2019ยฃ0.41-257.14%
2018-ยฃ0.26-27.08%
2017-ยฃ0.36-59.32%
2016-ยฃ0.88-21.85%
2015-ยฃ1.139.42%
2014-ยฃ1.032.87%
2013-ยฃ1.00-31.56%
2012-ยฃ1.46300%
2011-ยฃ0.37-45.56%
2010-ยฃ0.67-66.67%
2009-ยฃ2.02-63.51%
2008-ยฃ5.53-12.94%
2007-ยฃ6.3544.07%
2006-ยฃ4.4177.35%
2005-ยฃ2.4810.66%
2004-ยฃ2.25-54.25%
2003-ยฃ4.91-80.51%
2002-ยฃ25.183.87%
2001-ยฃ24.25116.17%
2000-ยฃ11.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ4.99-300.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ5.97 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ7.48-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.80-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ1.37-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA